Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ladarixin in recent-onset type 1 diabetes
MOH_2021-07-04_010111Phase 3Not yet recruiting
- Sponsor
- Dompé
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Ladarixin with Placebo (2 arms). Planned start Jun 2021; status: not yet recruiting.
02
Drugs
ladarixin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on MOH_2021-07-04_010111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-07-04_010111.